Next Article in Journal
Ascorbic Acid for the Safe Use of a Sunscreen Agent: Accumulation of Nano Zinc Oxide and Titanium Dioxide on the Skin
Previous Article in Journal
Comparison Study of Oral Iron Preparations Using a Human Intestinal Model
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Stability-Indicating HPLC Method for Posaconazole Bulk Assay

by
Cássia V. GARCIA
1,*,
Gislaine R. COSTA
2 and
Andreas S. L. MENDEZ
2
1
Departamento de Produção e Controle de Medicamentos, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS). Av. Ipiranga, 2752. Sala 406. CEP 90610-000, Porto Alegre/RS, Brazil
2
Laboratório de Desenvolvimento e Controle de Qualidade de Medicamentos, Universidade Federal do Pampa (UNIPAMPA). BR 472 km 585. CEP 97500-970, Uruguaiana/RS, Brazil
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2012, 80(2), 317-328; https://doi.org/10.3797/scipharm.1111-11
Submission received: 11 November 2011 / Accepted: 12 March 2012 / Published: 12 March 2012

Abstract

A stability-indicating liquid chromatographic (LC) method was developed for the determination of posaconazole in bulk. Chromatographic separation was achieved using an isocratic elution in a reversed-phase system, with a mobile phase composed of methanol-water (75:25, v/v), at 1.0 mL min−1 flow. Samples were exposed to degradation under thermal, oxidative and acid/basic conditions, and no interference in the analysis was observed. System suitability was evaluated and results were satisfactory (N = 4,900.00 tailing factor 1.04; RSD between injections = 0.65). The retention time of posaconazole was about 8.5 min and the method was validated within the concentration range 5–60 μg mL−1 (r = 0.9996). Adequate results were obtained for repeatability (RSD % = 0.86–1.22), inter-day precision (RSD % = 1.21) and accuracy (98.13% mean recovery). Robustness was also determined to be satisfactory after evaluation. The proposed method was successfully applied to posaconazole bulk quantification, showing the method is useful for determination of the drug in routine analysis.
Keywords: Posaconazole; Triazoles; HPLC; Stability-indicating assay; Bulk; Stress conditions Posaconazole; Triazoles; HPLC; Stability-indicating assay; Bulk; Stress conditions

Share and Cite

MDPI and ACS Style

GARCIA, C.V.; COSTA, G.R.; MENDEZ, A.S.L. Stability-Indicating HPLC Method for Posaconazole Bulk Assay. Sci. Pharm. 2012, 80, 317-328. https://doi.org/10.3797/scipharm.1111-11

AMA Style

GARCIA CV, COSTA GR, MENDEZ ASL. Stability-Indicating HPLC Method for Posaconazole Bulk Assay. Scientia Pharmaceutica. 2012; 80(2):317-328. https://doi.org/10.3797/scipharm.1111-11

Chicago/Turabian Style

GARCIA, Cássia V., Gislaine R. COSTA, and Andreas S. L. MENDEZ. 2012. "Stability-Indicating HPLC Method for Posaconazole Bulk Assay" Scientia Pharmaceutica 80, no. 2: 317-328. https://doi.org/10.3797/scipharm.1111-11

APA Style

GARCIA, C. V., COSTA, G. R., & MENDEZ, A. S. L. (2012). Stability-Indicating HPLC Method for Posaconazole Bulk Assay. Scientia Pharmaceutica, 80(2), 317-328. https://doi.org/10.3797/scipharm.1111-11

Article Metrics

Back to TopTop